Last 12 months
Inside the activity.
0 purchase rows · 76 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 19 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 17, 2023 Filed Jan 19, 2023 01:18 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,500 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001787306-23-000004 · wf-form4_167409108112700.xml · derivative · entry 4 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,958 Underlying: Common Stock · 8,500 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 01:18 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 8,500 | $13.72 | $116,654.85 |
DisclosureSEC source: 0001787306-23-000004 · wf-form4_167409108112700.xml · nonDerivative · entry 2 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,825 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 01:18 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 8,500 | $1.68 | $14,280.00 |
DisclosureSEC source: 0001787306-23-000004 · wf-form4_167409108112700.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:15 UTC |
Burnett PatrickSee Remarks
|
SaleCommon Stock | 1,475 | $15.01 | $22,136.06 |
DisclosureSEC source: 0001787306-23-000002 · wf-form4_167287050853068.xml · nonDerivative · entry 1 Burnett Patrick · CIK 0001741987 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,564 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:47 UTC |
Watanabe ToddDirector · See Remarks
|
SaleCommon Stock | 1,000 | $17.06 | $17,060.00 |
DisclosureSEC source: 0001787306-22-000079 · wf-form4_167062242477432.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,907 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 00:06 UTC |
Matsuda MasaruSee Remark
|
SaleCommon Stock | 1,720 | $18.19 | $31,288.86 |
DisclosureSEC source: 0001787306-22-000077 · wf-form4_166916195632010.xml · nonDerivative · entry 2 Matsuda Masaru · CIK 0001798679 · See Remark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,535 F3 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable withholding taxes. F2 · balance_after: Includes 13,300 Restricted Stock Units ("RSUs"). Read SEC document |
| November 18, 2022 Filed Nov 23, 2022 00:06 UTC |
Matsuda MasaruSee Remark
|
GrantCommon Stock | 4,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001787306-22-000077 · wf-form4_166916195632010.xml · nonDerivative · entry 1 Matsuda Masaru · CIK 0001798679 · See Remark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,255 F1 · shares: Represents performance stock units ("PSUs") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on November 18, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date. F2 · balance_after: Includes 13,300 Restricted Stock Units ("RSUs"). Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:29 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,020 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001787306-22-000075 · wf-form4_166872057856154.xml · derivative · entry 4 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,458 Underlying: Common Stock · 1,020 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:29 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 3,403 | $20.01 | $68,102.54 |
DisclosureSEC source: 0001787306-22-000075 · wf-form4_166872057856154.xml · nonDerivative · entry 2 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,825 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 8,812 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:29 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,020 | $1.68 | $1,713.60 |
DisclosureSEC source: 0001787306-22-000075 · wf-form4_166872057856154.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 8,812 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:39 UTC |
Watanabe ToddDirector · See Remarks
|
SaleCommon Stock | 1,000 | $18.00 | $18,004.00 |
DisclosureSEC source: 0001787306-22-000073 · wf-form4_166802996099874.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,907 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $17.94 to $18.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 109,925 Restricted Stock Units. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 22:47 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 1,000 | $19.51 | $19,510.00 |
DisclosureSEC source: 0001567619-22-018418 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,907 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 20:26 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 6,000 | $20.29 | $121,766.40 |
DisclosureSEC source: 0001567619-22-018322 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,208 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $20.06 to $20.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 8,812 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 20:37 UTC |
Burrows Scott LChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-22-017633 · doc1.xml · derivative · entry 2 Burrows Scott L · CIK 0001853327 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,277 Underlying: Common Stock · 5,000 shares Expires 2029-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the one year anniversary measured from May 22, 2019 (the "Vesting Commencement Date") and 1/48th of the shares vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 20:37 UTC |
Burrows Scott LChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $1.68 | $8,403.00 |
DisclosureSEC source: 0001567619-22-017633 · doc1.xml · nonDerivative · entry 1 Burrows Scott L · CIK 0001853327 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 17,400 restricted stock units. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 21:10 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 1,000 | $21.51 | $21,510.00 |
DisclosureSEC source: 0001567619-22-017237 · doc1.xml · nonDerivative · entry 2 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,907 F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F1 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 23:08 UTC |
Krishnamohan NehaDirector
|
GrantStock Option (Right to Buy) · Derivative | 29,482 | $0.00 Strike: $24.11 | $0.00 |
DisclosureSEC source: 0001567619-22-017088 · doc1.xml · derivative · entry 1 Krishnamohan Neha · CIK 0001866171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,482 Underlying: Common Stock · 29,482 shares Expires 2032-09-02 F1 · derivative.exercise_date: The option vests as to 1/3rd of the total shares on each of September 2, 2023, September 2, 2024 and September 2, 2025, subject to Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| August 18, 2022 Filed Mar 4, 2026 01:41 UTC |
Burnett PatrickSee Remarks
|
GrantCommon Stock | 16,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014324 · wk-form4_1772588506.xml · nonDerivative · entry 1 Burnett Patrick · CIK 0001741987 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,401 F1 · kind: On August 8, 2020, the Reporting Person was granted performance-based Restricted Stock Units ("RSUs") subject to a milestone condition. The Compensation Committee of the Issuer certified the achievement of the milestone and commencement of vesting on August 18, 2022. The remaining RSUs vested in three substantially equal annual installments, such that the RSUs fully vested on August 18, 2025. F2 · balance_after: Reflects holdings following the August 18, 2022 transaction reported herein. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:06 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 6,000 | $24.80 | $148,788.60 |
DisclosureSEC source: 0001567619-22-016413 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,208 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $24.51 to $25.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 8,812 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:34 UTC |
Frazier Life Sciences VIII, L.P.10% owner
FHM LIFE SCIENCES VIII, L.P.10% owner
FHM LIFE SCIENCES VIII, L.L.C.10% owner
Topper James N10% owner
Heron Patrick JDirector · 10% owner
|
PurchaseCommon Stock | 250,000 | $20.00 | $5,000,000.00 |
DisclosureSEC source: 0001209191-22-045014 · doc4.xml · nonDerivative · entry 1 Frazier Life Sciences VIII, L.P. · CIK 0001655827 · 10% owner FHM LIFE SCIENCES VIII, L.P. · CIK 0001698755 · 10% owner FHM LIFE SCIENCES VIII, L.L.C. · CIK 0001698823 · 10% owner Topper James N · CIK 0001341382 · 10% owner Heron Patrick J · CIK 0001365617 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,684,232 Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-22-015354 · doc1.xml · derivative · entry 7 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,348 Underlying: Common Stock · 2,500 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F8 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 2,500 | $24.74 | $61,858.00 |
DisclosureSEC source: 0001567619-22-015354 · doc1.xml · nonDerivative · entry 2 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 651,871 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $24.35 to $25.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:16 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionCommon Stock | 2,500 | $1.68 | $4,201.50 |
DisclosureSEC source: 0001567619-22-015354 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| July 18, 2022 Filed Jul 18, 2022 22:53 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 6,000 | $24.40 | $146,373.60 |
DisclosureSEC source: 0001567619-22-014131 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,208 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $24.24 to $24.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 8,812 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 19:30 UTC |
OSBORNE DAVID WChief Technical Officer
|
SaleCommon Stock | 2,197 | $25.41 | $55,835.44 |
DisclosureSEC source: 0001567619-22-013925 · doc1.xml · nonDerivative · entry 1 OSBORNE DAVID W · CIK 0001252999 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,649 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $25.00 to $25.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 24,925 RSUs. F4 · balance_after: Reflects the adjusted total which includes the purchase of 1,617 shares under the Arcutis Employee Stock Purchase Plan on May 31, 2022. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 23:30 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,087 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-22-013924 · doc1.xml · derivative · entry 9 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,848 Underlying: Common Stock · 7,087 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F8 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 23:30 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 7,087 | $25.41 | $180,111.85 |
DisclosureSEC source: 0001567619-22-013924 · doc1.xml · nonDerivative · entry 4 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 651,871 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $25.00 to $25.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 23:30 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionCommon Stock | 7,087 | $1.68 | $11,910.41 |
DisclosureSEC source: 0001567619-22-013924 · doc1.xml · nonDerivative · entry 3 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 23:30 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 4,913 | $25.41 | $124,860.95 |
DisclosureSEC source: 0001567619-22-013924 · doc1.xml · nonDerivative · entry 2 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 651,871 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $25.00 to $25.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 23:30 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 1,500 | $25.00 | $37,500.00 |
DisclosureSEC source: 0001567619-22-013924 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 656,784 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:04 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 1,000 | $22.07 | $22,070.00 |
DisclosureSEC source: 0001567619-22-013783 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,284 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:29 UTC |
ORBIMED ADVISORS LLC10% owner
ORBIMED CAPITAL LLC10% owner
OrbiMed Capital GP VII LLC10% owner
|
SaleCommon Stock | 35,944 | $21.31 | $765,966.64 |
DisclosureSEC source: 0000947871-22-000727 · ownership.xml · nonDerivative · entry 2 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner ORBIMED CAPITAL LLC · CIK 0001157524 · 10% owner OrbiMed Capital GP VII LLC · CIK 0001760648 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 415,142 F1 · price: These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $21.17 to $21.75. The price reported reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Shares are held of record by OrbiMed Partners Master Fund Limited ("OPM"). OrbiMed Capital LLC ("OrbiMed Capital") is the investment advisor to OPM. OrbiMed Capital exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPM. F4 · ownership.nature: This report on Form 4 is filed by OrbiMed Advisors, OrbiMed GP VII and OrbiMed Capital. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:29 UTC |
ORBIMED ADVISORS LLC10% owner
ORBIMED CAPITAL LLC10% owner
OrbiMed Capital GP VII LLC10% owner
|
SaleCommon Stock | 306,027 | $21.31 | $6,521,435.37 |
DisclosureSEC source: 0000947871-22-000727 · ownership.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner ORBIMED CAPITAL LLC · CIK 0001157524 · 10% owner OrbiMed Capital GP VII LLC · CIK 0001760648 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,534,537 F1 · price: These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $21.17 to $21.75. The price reported reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Shares are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP VII") is the general partner of OPI VII, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of OrbiMed GP VII. OrbiMed GP VII and OrbiMed Advisors may be deemed to have voting and investment power over the securities held by OPI VII. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI VII. F4 · ownership.nature: This report on Form 4 is filed by OrbiMed Advisors, OrbiMed GP VII and OrbiMed Capital. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| June 23, 2022 Filed Sep 9, 2022 21:10 UTC |
Watanabe ToddDirector · President and CEO
|
GiftCommon Stock | 268,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-017237 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,907 F1 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 20:06 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 1,000 | $21.06 | $21,064.00 |
DisclosureSEC source: 0001567619-22-012377 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,284 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $20.84 to $21.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Reflects the adjusted total which includes the purchase of 1,617 shares under the Arcutis Employee Stock Purchase Plan on May 31, 2022. F4 · balance_after: Includes 109,925 restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 2, 2022 20:48 UTC |
Matsuda MasaruSVP and General Counsel
|
SaleCommon Stock | 1,795 | $19.73 | $35,418.58 |
DisclosureSEC source: 0001567619-22-012149 · doc1.xml · nonDerivative · entry 2 Matsuda Masaru · CIK 0001798679 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,380 F3 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable withholding taxes. F4 · price: The transaction was executed in multiple trades in prices ranging from $19.7201 to $19.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 13,300 RSUs. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:48 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-22-012144 · doc1.xml · derivative · entry 4 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,478 Underlying: Common Stock · 2,500 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:48 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 2,500 | $20.62 | $51,538.50 |
DisclosureSEC source: 0001567619-22-012144 · doc1.xml · nonDerivative · entry 2 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,896 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The transaction was executed in multiple trades in prices ranging from $20.285 to $20.92, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Includes 4,500 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:48 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 2,500 | $1.68 | $4,201.50 |
DisclosureSEC source: 0001567619-22-012144 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 4,500 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:58 UTC |
Curran TerrieDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $20.29 | $0.00 |
DisclosureSEC source: 0001567619-22-012323 · doc1.xml · derivative · entry 2 Curran Terrie · CIK 0001690298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2032-06-01 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:58 UTC |
Curran TerrieDirector
|
GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012323 · doc1.xml · nonDerivative · entry 1 Curran Terrie · CIK 0001690298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 F1 · balance_after: Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:57 UTC |
CHAUDHURI BHASKARDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $20.29 | $0.00 |
DisclosureSEC source: 0001567619-22-012321 · doc1.xml · derivative · entry 3 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2032-06-01 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:57 UTC |
CHAUDHURI BHASKARDirector
|
GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012321 · doc1.xml · nonDerivative · entry 1 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845,703 F1 · balance_after: Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:52 UTC |
Leonard Keith RDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $20.29 | $0.00 |
DisclosureSEC source: 0001567619-22-012311 · doc1.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2032-06-01 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:52 UTC |
Leonard Keith RDirector
|
GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012311 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 F1 · balance_after: Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:51 UTC |
TURNER JOSEPH LDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $20.29 | $0.00 |
DisclosureSEC source: 0001567619-22-012310 · doc1.xml · derivative · entry 2 TURNER JOSEPH L · CIK 0001266129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2032-06-01 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:51 UTC |
TURNER JOSEPH LDirector
|
GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012310 · doc1.xml · nonDerivative · entry 1 TURNER JOSEPH L · CIK 0001266129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 F1 · balance_after: Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:53 UTC |
Heron Patrick JDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $20.29 | $0.00 |
DisclosureSEC source: 0001567619-22-012314 · doc1.xml · derivative · entry 2 Heron Patrick J · CIK 0001365617 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2032-06-01 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:53 UTC |
Heron Patrick JDirector · 10% owner
|
GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012314 · doc1.xml · nonDerivative · entry 1 Heron Patrick J · CIK 0001365617 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 F1 · balance_after: Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:56 UTC |
Gilbert Halley EDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,796 | $0.00 Strike: $20.29 | $0.00 |
DisclosureSEC source: 0001567619-22-012319 · doc1.xml · derivative · entry 2 Gilbert Halley E · CIK 0001601360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 Underlying: Common Stock · 11,796 shares Expires 2032-06-01 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.